Today: 24 April 2026
Tesla stock price jumps on Bank of America upgrade as Europe sales slump and carbon credits loom
4 March 2026
2 mins read

Tesla stock price jumps on Bank of America upgrade as Europe sales slump and carbon credits loom

New York, March 4, 2026, 16:10 EST — After-hours trading.

  • On Wednesday, Tesla shares jumped roughly 3.4%, closing at $406.10.
  • Bank of America resumed coverage, slapped a buy on the stock, and set the price target at $460.
  • Europe was still grabbing attention—UK sales dropped, and EU filings flagged a shift for Tesla’s 2026 emissions-credit pooling.

Tesla (TSLA.O) climbed 3.4% Wednesday, closing at $406.10 after Bank of America issued a bullish note. Shares fluctuated from $389.60 up to $408.29 over the course of the session.

This shift is significant: Tesla’s stock often reacts sharply to ratings shifts, sometimes coloring the session’s mood. Investors are still wrestling with how to value Tesla’s autonomy and robotics bets, all while gauging if the company’s main car business can stabilize amid heavier competition.

Europe is making noise too: fresh monthly sales figures, some regulatory-credit moves, and ongoing labor disputes at Tesla’s sole European factory are all landing at once. Individually, these stories may not move markets every day, but they’re often enough to tilt sentiment fast.

Bank of America is back with coverage on Tesla, tagging the stock with a “buy” and eyeing a $460 target, Investopedia reports. Tesla, they wrote, is “the current leader in consumer autonomy” and primed to move fast into robotaxi services. The note highlights upside tied to driver-assistance tech, Optimus robots, and energy storage as well. Investopedia

An EU filing lists Stellantis, Toyota and Subaru as absent from Tesla’s 2026 carbon-credit “pool,” a system automakers use to combine fleets and trade credits to stay within EU CO2 limits. Stellantis isn’t part of the Tesla Pool for 2026 “currently,” though the company left the door open to joining later. Toyota Europe said automakers can opt in until December 2026—“it’s too early to confirm if we need to pool or not,” a spokesman told Reuters. Reuters

Tesla shifted 2,208 cars in the UK last month, a steep 45.2% slide from February last year, according to figures from New Automotive. BYD, on the other hand, booked a 40.9% jump, reaching 968 sales. New Automotive also flagged that Tesla’s year-to-date sales are off by 5%—notable, given the brand’s reputation for choppy delivery numbers. “It is fantastic to see one in four motorists opting for an electric car in February,” said Ben Nelmes, chief executive at New Automotive. Reuters

IG Metall came up short again in its bid to win control over the works council at Tesla’s Grünheide factory outside Berlin, Reuters reported. The union picked up 13 out of 37 seats. Works councils—employee-elected—handle labor talks with management. IG Metall has the upper hand at companies like Volkswagen, BMW, and Mercedes, but Tesla remains a tough nut. “Unfortunately, it was not enough to secure a … majority,” said Laura Arndt, the union’s lead candidate. Reuters

That combination is another headache for investors. Regulatory credits often move the profit needle, and Europe remains the real proving ground for both demand and pricing—Tesla’s Berlin plant anchors its manufacturing presence in the region.

Still, the upgrade’s bullish thesis hinges on both execution and regulatory progress—neither known for speed. A hiccup in Tesla’s driver-assist adoption, any holdup with the robotaxi rollout, or a drop in automaker demand for EU pooling deals (thanks to loosened timelines) could quickly sap momentum. Tesla’s stock, for its part, has shown it doesn’t take much to reverse course.

Coming up Thursday (March 5), U.S. traders will be tracking for any momentum after the upgrade, plus fresh European registration numbers. Eyes also stay on whether automakers jump into—or steer clear of—Tesla’s 2026 emissions-credit pool, with the December 2026 deadline still looming.

Stock Market Today

  • 3 TSX Stocks to Own Amid Market Volatility
    April 24, 2026, 1:32 PM EDT. Volatility in markets demands stocks with strong cash flow, solid brands, and resilient management. Three TSX picks fit the bill. Loblaw (TSX:L) showed a 6.3% rise in retail revenue and expanded with a $2.4 billion 2026 plan, highlighting growth despite cautious consumers. Restaurant Brands (TSX:QSR), owner of Tim Hortons and Burger King, posted a 10.7% EPS gain and continues international expansion, supported by a 3.4% dividend yield. TFI International (TSX:TFII), spanning North American logistics, faces freight softness and rising diesel costs but remains a notable player. These stocks offer defensive qualities with growth potential, suited for choppy markets.

Latest article

Eos Energy Enterprises Sets Q1 Earnings Date as EOSE Stock Jumps — May 13 Is the Real Test

Eos Energy Enterprises Sets Q1 Earnings Date as EOSE Stock Jumps — May 13 Is the Real Test

24 April 2026
Eos Energy Enterprises will report first-quarter results before the U.S. market opens May 13, after previewing revenue of $56 million to $57 million and a 17% rise in shipments. Shares traded at $7.78, up 12%, with volume at 25.6 million. Eos recently signed a joint development deal with TURBINE-X for AI power infrastructure. The company’s second battery line completed factory acceptance testing last quarter.
Charter Communications Stock Plunges After Broadband Losses Rattle Wall Street

Charter Communications Stock Plunges After Broadband Losses Rattle Wall Street

24 April 2026
Charter Communications shares fell 22% Friday after the company lost 120,000 internet customers in the first quarter, double last year’s loss and worse than analyst forecasts. Revenue slipped 1% to $13.6 billion; net income dropped to $1.16 billion. The stock traded at $187.65, down $54.13. Charter is still seeking California approval to close its $34.5 billion Cox Communications deal.
Eli Lilly’s New Weight-Loss Pill Has an Early Problem: Novo’s Head Start

Eli Lilly’s New Weight-Loss Pill Has an Early Problem: Novo’s Head Start

24 April 2026
Eli Lilly’s new oral weight-loss drug Foundayo was prescribed 3,707 times in its second week on the U.S. market, well below Novo Nordisk’s oral Wegovy, which saw 18,410 prescriptions in the same period after launch. Lilly shares fell about 4% following the data, while Novo Nordisk’s U.S. shares rose nearly 6%. Foundayo was approved by the FDA on April 1 and began shipping April 6.
Oracle cloud outage hits TikTok U.S. again as March 10 earnings near
Previous Story

Oracle cloud outage hits TikTok U.S. again as March 10 earnings near

Silver price rebounds after Tuesday selloff as dollar cools and jobs data looms
Next Story

Silver price rebounds after Tuesday selloff as dollar cools and jobs data looms

Go toTop